Who owns AGIOS PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of AGIO from SEC Form 13F filings across 243 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 243 institutions disclosed 67.3M shares of AGIOS PHARMACEUTICALS, INC. worth $2.24B — about 112.7% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
243
13F holders
$2.24B
value, 2026 filers
112.7%
of shares outstanding (67.3M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of AGIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.2M | $207.1M | 0.0% | 10.4% | -3.5% |
| 2 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 5.9M | $197.5M | 0.9% | 9.9% | +0.4% |
| 3 | D. E. Shaw & Co., Inc. | 3.9M | $129.3M | 0.1% | 6.5% | +25.2% |
| 4 | MORGAN STANLEY | 3.4M | $114.3M | 0.0% | 5.8% | +256.8% |
| 5 | STATE STREET CORP | 3.3M | $108.5M | 0.0% | 5.5% | -7.6% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | $94.8M | 0.0% | 4.8% | -1.7% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $89.4M | 0.0% | 4.5% | +0.2% |
| 8 | ARMISTICE CAPITAL, LLC | 2.6M | $85.7M | 1.1% | 4.3% | +7.4% |
| 9 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.0M | $65.1M | 0.1% | 3.3% | -7.2% |
| 10 | Assenagon Asset Management S.A. | 1.9M | $62.7M | 0.1% | 3.2% | +1714.6% |
| 11 | Erste Asset Management GmbH | 1.8M | $60.1M | 0.4% | 3% | -16.2% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $52.6M | 0.0% | 2.6% | +0.5% |
| 13 | GW&K Investment Management, LLC | 1.4M | $46.4M | 0.4% | 2.3% | +15.7% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.3M | $43.9M | 0.0% | 2.2% | -4.1% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $42.8M | 0.0% | 2.2% | +3.0% |
| 16 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.2M | $41.4M | 0.0% | 2.1% | -2.7% |
| 17 | GOLDMAN SACHS GROUP INC | 1.1M | $38.1M | 0.0% | 1.9% | -0.4% |
| 18 | ADAR1 Capital Management, LLC | 1.1M | $37.9M | 1.7% | 1.9% | -11.5% |
| 19 | UBS Group AG | 921,337 | $30.6M | 0.0% | 1.5% | -6.5% |
| 20 | TWO SIGMA INVESTMENTS, LP | 906,037 | $30.1M | 0.0% | 1.5% | +68.9% |
| 21 | Foresite Capital Management VI LLC | 827,128 | $27.5M | 4.9% | 1.4% | +5.4% |
| 22 | CITADEL ADVISORS LLC | 778,581 | $25.9M | 0.0% | 1.3% | +6.3% |
| 23 | AQR CAPITAL MANAGEMENT LLC | 746,896 | $24.8M | 0.0% | 1.3% | +9.1% |
| 24 | BANK OF AMERICA CORP /DE/ | 714,874 | $23.8M | 0.0% | 1.2% | +40.8% |
| 25 | Nuveen, LLC | 680,983 | $22.6M | 0.0% | 1.1% | -22.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.